SGLT2 Inhibition Across a Range of Left Ventricular Hypertrophy, with Muthiah Vaduganathan, MD, MPH

Muthiah Vaduganathan, MD, MPH, discusses a presentation from ACC.24 assessing the effects of dapagliflozin across a range of left ventricular hypertrophy from DELIVER.

Related Keywords

Campbellp Dapagliflozin ,Muthiah Vaduganathan ,Boehringer Ingelheim Pharmaceuticals ,Astrazeneca ,Bayer Ag ,Amgen ,American College Of Cardiology ,American College ,Annual Scientific Sessions ,Cardiometabolic Implementation Science ,Hazard Ratio ,Confidence Interval ,Annual Scientific ,